Results 201 to 210 of about 397,447 (350)
Commentary: Constructing the optimal experimental autoimmune thyroiditis mouse model using porcine thyroglobulin. [PDF]
Li M, Zhou Y, Cai M.
europepmc +1 more source
Iodine is a vital micronutrient necessary for thyroid hormone synthesis, growth, and neurodevelopment. Universal salt iodization was implemented globally, including in Nepal, to address the burden of iodine deficiency diseases. Despite the success, iodine loss from iodized salt due to temperature and storage practices remains an issue.
Yugesh Paudel +4 more
wiley +1 more source
Paediatric Autoimmune Thyroiditis Triggered by Prior SARS-CoV-2 Exposure: A Case with Transient Hashitoxicosis. [PDF]
Rodina L +4 more
europepmc +1 more source
FT3 Levels and Systemic Inflammation: Evidence From a Population‐Based NHANES Analysis
Objective Previous studies suggest a complex interaction between 3,3′,5‐triiodo‐L‐thyronine (T3) and inflammation, but this relationship remains unclear. This study investigates the association between free triiodothyronine (FT3) levels and inflammatory markers in the US population using National Health and Nutrition Examination Survey (NHANES) data ...
Liu Yang +7 more
wiley +1 more source
Differential Association of Serum TSH with Differentiated Thyroid Cancer Risk by Autoimmune Thyroiditis Status. [PDF]
Yu L +11 more
europepmc +1 more source
Introduction Type 1 diabetes mellitus (T1DM) is an autoimmune disease that damages insulin‐producing pancreatic cells, often appearing in childhood. Global incidence is rising at 2%–3% yearly. Its exact cause is unclear. Prenatal exposures and maternal autoimmune disorders have been reported as potential risk factors.
Hsin-Chien Yen +3 more
wiley +1 more source
Shortness of Breath in a 61-Year-Old Man With a History of Autoimmune Thyroiditis. [PDF]
Bowens BK +3 more
europepmc +1 more source
THE EFFECT OF AUTOIMMUNE THYROIDITIS ON THE SEVERITY OF ABNORMAL UTERINE BLEEDING
O. S. Alieksieieva +1 more
openalex +1 more source
Abstract Although poly(adenosine diphosphate‐ribose) polymerase inhibitors (PARPis) and bevacizumab were approved as first‐line maintenance for advanced ovarian cancer (OC), evidence comparing this combination with PARPi monotherapy, especially in BRCA‐mutated/homologous recombination‐deficient (HRD) patients, is lacking.
Lingying Wu +56 more
wiley +1 more source
Myopericarditis Secondary to Silent Autoimmune Thyroiditis: A Case of Severe Thyrotoxicosis. [PDF]
Hernández PAM +2 more
europepmc +1 more source

